Vimarsana
Biggest News Aggregation in the World

Page 9 - E Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from E Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In E Ltd Today - Breaking & Trending Today

USD 54.39 Mn growth opportunity in Japanese Encephalitis Vaccines Market | 5.38% YOY growth expected in 2022 - Vimarsana News

USD 54.39 Mn growth opportunity in Japanese Encephalitis Vaccines Market | 5.38% YOY growth expected in 2022

/PRNewswire/ -- The Japanese encephalitis vaccines market size is expected to increase by USD 58.27 million between 2021 and 2026, expanding at a CAGR of 6%...

Corbevax COVID-19 vaccine price slashed to Rs 250 per dose - Vimarsana News

Corbevax COVID-19 vaccine price slashed to Rs 250 per dose

It would result in end users paying a price of Rs 400 a dose, including taxes and administration charges

Corbevax price slashed to Rs 250 per dose - Vimarsana News

Corbevax price slashed to Rs 250 per dose

Vaccine maker Biological E. Ltd (BE) on Monday announced that it has reduced the price of its Covid-19 vaccine corbevax, from Rs 840 to Rs 250 a dose inclusive of GST, for private Covid-19 vaccination centres.For the end user,the price would be ...

Dengue Vaccines Market Expected to cross US$ 1 Billion by The End of 2031 - Vimarsana News

Dengue Vaccines Market Expected to cross US$ 1 Billion by The End of 2031

The global dengue vaccines market is poised to expand at a staggering double-digit CAGR through 2031, surpassing US$ 1 billion during the forecast period, concludes ESOMAR-certified market research company Future Market Insights (FMI) in its recently published report.Growth is majorly underpinned by the rising incid...

World Moves From Shortages to Possible Glut of Covid-19 Vaccines - Vimarsana News

World Moves From Shortages to Possible Glut of Covid-19 Vaccines

(Bloomberg) -- After racing to build capacity and meet once seemingly insatiable orders for Covid-19 shots, the global vaccine industry is facing waning demand as many late-to-market producers fight over a slowing market.